Insider trade

Newtekone (NEWT): CEO received 3,595 shares

Barry Sloane, CEO at Newtekone, reported a grant / award of 3,595 shares.

3,595
Shares · @ $13.91
Traded
Jan 14, 2026
Filed
Jan 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 1, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  2. Dec 5, 2025Insider · 5 days before resultsDirector purchased ~$8.9K of NEWT shares in the open market
  3. Dec 8, 2025Insider · 2 days before resultsDirector purchased ~$10K of NEWT shares in the open market
  4. Dec 10, 2025Company filing · Form 8-K · ResultsReported its results
  5. Dec 15, 2025InsiderDirector purchased ~$6K of NEWT shares in the open market
  6. Jan 8, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

What came next

  1. Jan 21, 2026Company filing · Form 8-K · ResultsReported its results
  2. Jan 29, 2026Company filing · Form 8-K · ResultsReported its results
  3. Jan 29, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 27, 2026, the Board of Directors (the “Board”) of NewtekOne, Inc. (the “Company”) increased the number of directors constituting the entire Board from seven to eight, and elected Thomas Cestare to serve as a Class I director of the Company, which term will expire at the Company’s Annual Meeting of Shareholders in 2027, and to hold such position until his successor is elected and shall qualify.”
  4. Feb 17, 2026Company filing · Form 8-K · New debt, Other newsTook on new debt or obligations, and reported other company news
  5. Mar 13, 2026Company filing · Form 8-K · ResultsReported its results
  6. Mar 13, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  7. Apr 1, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 1, 2026, NewtekOne, Inc. (the “Company”) renewed for additional one-year terms the employment agreements with its executive officers Barry Sloane, Chief Executive Officer and President (the “Sloane Employment Agreement”); Michael A. Schwartz, Chief Legal Officer and Corporate Secretary (the “Schwartz Employment Agreement”); and Frank DeMaria, Chief Financial Officer and Executive Vice President (the…”
  8. Apr 6, 2026Company filing · Form 8-K · ResultsReported its results
  9. Apr 28, 2026Company filing · Form 8-K · New debt, Other newsTook on new debt or obligations, and reported other company news
  10. Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
  11. May 7, 2026InsiderDirector purchased ~$13K of NEWT shares in the open market
  12. May 8, 2026InsiderDirector purchased ~$14K of NEWT shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Newtekone

OQRO holds no insider, Congress, fund or contract record for Newtekone dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NEWT page.

Other recent filings by Barry Sloane, President, Chairman & CEO

The full history of Barry Sloane, President, Chairman & CEO is on the profile page.

How this filing works

Explore the data

Other disclosures at Newtekone

Everything OQRO holds on this company is on its NEWT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data